) restricts either drug from referring to Herceptin, in ???data relating to its manufacturing process, safety, efficacy and sales, in any press releases, public announcements, promotional or other material for the defendants' drugs.???In an official statement sent to Biopharma-Reporter.com from Mylan said the two firms ???were given no notice of these proceedings, nor were they given an opportunit